Drugs: Prices

Department of Health and Social Care written question – answered at on 30 January 2023.

Alert me about debates like this

Photo of Chris Green Chris Green Conservative, Bolton West

To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the impact of the NHS continuing to adopt uniform pricing by medicine on patient access to innovative medicines.

Photo of Will Quince Will Quince Minister of State (Department of Health and Social Care)

No assessment has been made. NHS England set out their commercial approach to new medicines in the Commercial Framework published in February 2021. The framework sets out, in line with commitments made under the Voluntary scheme for branded medicines pricing and access (VPAS), that the National Health Service can reach complex confidential commercial arrangements with companies that bring new medicines to the market which offer greater levels of health gain relative to cost. The commercial framework allows the flexibility to create different commercial approaches where the importance of the medicine warrants it.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.